How do newer biologic agents like IL-17 inhibitors compare to traditional biologics in psoriasis treatment?

Featuring Raj Chovatiya, MD, PhD, MSCI | Associate Professor, Rosalind Franklin University of Medicine and Science, Chicago Medical School; Founder and Director,Center for Medical Dermatology + Immunology Research,Chicago, IL | Published July 17, 2024